A conserved antioxidant response element (ARE) in the promoter of human carbonyl reductase 3 (CBR3) mediates induction by the master redox switch Nrf2

This publication has 36 references indexed in Scilit:

• Anthracycline-Related Cardiomyopathy After Childhood Cancer: Role of Polymorphisms in Carbonyl Reductase Genes—A Report From the Children's Oncology Group
  Journal of Clinical Oncology, 2012
• Should Supplemental Antioxidant Administration Be Avoided During Chemotherapy and Radiation Therapy?
  JNCI: Journal of the National Cancer Institute, 2008
• Reactive carbonyls and oxidative stress: Potential for therapeutic intervention
  Pharmacology & Therapeutics, 2007
• Contribution of NAD(P)H:quinone oxidoreductase 1 to protection against carcinogenesis, and regulation of its gene by the Nrf2 basic-region leucine zipper and the arylhydrocarbon receptor basic helix-loop-helix transcription factors
  Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2004
• Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity
  Pharmacological Reviews, 2004
• Protection from doxorubicin-induced cardiac toxicity in mice with a null allele of carbonyl reductase 1.
  2003
• Quantification of mRNA using real-time reverse transcription PCR (RT-PCR): trends and problems
  Journal of Molecular Endocrinology, 2002
• Antioxidant regulation of genes encoding enzymes that detoxify xenobiotics and carcinogens
  2001
• Human carbonyl reductase overexpression in the heart advances the development of doxorubicin-induced cardiotoxicity in transgenic mice.
  2000
• Doxorubicin cardiotoxicity may be caused by its metabolite, doxorubicinol.
  Proceedings of the National Academy of Sciences, 1988